References
- World Health Organization (WHO). Pertussis vaccines: WHO position paper. Wkly Epidemiol Rec 2010; 85:385 - 400; PMID: 20939150
- Forsyth KD, Wirsing von Konig CH, Tan T, Caro J, Plotkin S. Prevention of pertussis: recommendations derived from the second Global Pertussis Initiative roundtable meeting. Vaccine 2007; 25:2634 - 42; http://dx.doi.org/10.1016/j.vaccine.2006.12.017; PMID: 17280745
- Edwards KM, Decker MD. Pertussis vaccines. In: Plotkin SA, Orenstein WA, Offit P, eds. Vaccines. 7th ed. Philadelphia, PA: WB Saunders Company; 2008:467-517.
- Vryheid RE, Kane MA, Muller N, Schatz GC, Bezabeh S. Infant and adolescent hepatitis B immunization up to 1999: a global overview. Vaccine 2000; 19:1026 - 37; http://dx.doi.org/10.1016/S0264-410X(00)00239-5; PMID: 11137236
- World Health Organization (WHO). Hepatitis B vaccines. Wkly Epidemiol Rec 2009; 84:405 - 19; PMID: 19817017
- World Health Organization (WHO). Expanded programme on immunization. global advisory group: Part I. Wkly Epidemiol Rec 1992; 67:11 - 5; PMID: 1736955
- World Health Organization. WHO position paper on Haemophilus influenzae type b conjugate vaccines. (Replaces WHO position paper on Hib vaccines previously published in the Weekly Epidemiological Record. Wkly Epidemiol Rec 2006; 81:445 - 52; PMID: 17124755
- World Health Organization (WHO). Introducing haemophilus influenzae type b conjugate vaccine into national immunization services. WHO fact sheet 2001.
- Chandran A, Watt J, Santosham M. Haemophilus influenzae vaccines. In: Plotkin SA, Orenstein WA, Offit P, eds. Vaccines. 7th ed. Philadelphia, PA: WB Saunders Company; 2008:157-176.
- Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev 2000; 13:302 - 17; http://dx.doi.org/10.1128/CMR.13.2.302-317.2000; PMID: 10756001
- World Health Organization (WHO). The children's vaccine initiative and the global programme for vaccines and immunization. recommendations from the special advisory group of experts. part I. Wkly Epidemiol Rec 1996; 71:261 - 6; PMID: 8826779
- Decker M, Edwards K, Bogaerts H. Combination vaccines. In: Plotkin SA, Orenstein WA, Offit P, eds. Vaccines. 7th ed. Philadelphia, PA: WB Saunders Company; 2008:1069-1101.
- European Medicines Agency (EMA). Scientific discussion; quintanrix.
- Riedemann S, Reinhardt G, Jara J, Rios R, Wenzel MS, Willems P, et al. Immunogenicity and reactogenicity of combined versus separately administered DTPw-HBV and Hib vaccines given to healthy infants at 2, 4 and 6 months of age, with a booster at 18 months. Int J Infect Dis 2002; 6:215 - 22; http://dx.doi.org/10.1016/S1201-9712(02)90114-1; PMID: 12718838
- Gatchalian S, Reyes M, Bernal N, Lefevre I, David MP, Han HH, et al. A new DTPw-HBV/Hib vaccine is immunogenic and safe when administered according to the EPI (Expanded Programme for Immunization) schedule and following hepatitis B vaccination at birth. Hum Vaccin 2005; 1:198 - 203; http://dx.doi.org/10.4161/hv.1.5.2163; PMID: 17012860
- Wiedenmayer KA, Weiss S, Chattopadhyay C, Mukherjee A, Kundu R, Ayé R, et al. Simplifying paediatric immunization with a fully liquid DTP-HepB-Hib combination vaccine: evidence from a comparative time-motion study in India. Vaccine 2009; 27:655 - 9; http://dx.doi.org/10.1016/j.vaccine.2008.11.045; PMID: 19056443
- Drain PK, Nelson CM, Lloyd JS. Single-dose versus multi-dose vaccine vials for immunization programmes in developing countries. Bull World Health Organ 2003; 81:726 - 31; PMID: 14758432
- Kanra G, Kara A, Demiralp O, Contorni M, Hilbert AK, Spyr C, et al. Safety and immunogenicity of a new fully liquid DTPw-HepB-Hib combination vaccine in infants. Hum Vaccin 2006; 2:155 - 60; http://dx.doi.org/10.4161/hv.2.4.2942; PMID: 17012890
- Gentile A, Umido V, Czerniuk P, Nacul J, Seigelchifer M, Hilbert AK, et al. Immunogenicity and reactogenicity of a combined fully liquid DTPw-HepB-Hib pentavalent vaccine in healthy infants: no clinically relevant impact of a birth dose of hepatitis B vaccine. Int J Infect Dis 2011; 15:e24 - 9; http://dx.doi.org/10.1016/j.ijid.2010.09.004; PMID: 21093342
- Suárez E, Asturias EJ, Hilbert AK, Herzog C, Aeberhard U, Spyr C. A fully liquid DTPw-HepB-Hib combination vaccine for booster vaccination of toddlers in El Salvador. Rev Panam Salud Publica 2010; 27:117 - 24; http://dx.doi.org/10.1590/S1020-49892010000200005; PMID: 20339615
- Trotter CL, McVernon J, Andrews NJ, Burrage M, Ramsay ME. Antibody to Haemophilus influenzae type b after routine and catch-up vaccination. Lancet 2003; 361:1523 - 4; http://dx.doi.org/10.1016/S0140-6736(03)13172-8; PMID: 12737867
- Nascimento-Carvalho CM, de Andrade AL. Haemophilus influenzae type b vaccination: long-term protection. J Pediatr (Rio J) 2006; 82:Suppl S109 - 14; http://dx.doi.org/10.2223/JPED.1501; PMID: 16826309
- Deinhardt F, Zuckerman AJ. Immunization against hepatitis B: report on a WHO meeting on viral hepatitis in Europe. J Med Virol 1985; 17:209 - 17; http://dx.doi.org/10.1002/jmv.1890170302; PMID: 4067587
- von Hunolstein C, Aggerbeck H, Andrews N, Berbers G, Fievet-Groyne F, Maple PA, et al. European sero-epidemiology network: standardisation of the results of diphtheria antitoxin assays. Vaccine 2000; 18:3287 - 96; http://dx.doi.org/10.1016/S0264-410X(00)00125-0; PMID: 10869774
- World Health Organization (WHO). The immunological basis for immunization series. module 3: Tetanus (galazka, AM).
- Mertsola J, Ruuskanen O, Kuronen T, Meurman O, Viljanen MK. Serologic diagnosis of pertussis: evaluation of pertussis toxin and other antigens in enzyme-linked immunosorbent assay. J Infect Dis 1990; 161:966 - 71; http://dx.doi.org/10.1093/infdis/161.5.966; PMID: 2324547
- Mariani M, Luzzi E, Proietti D, Mancianti S, Casini D, Costantino P, et al. A competitive enzyme-linked immunosorbent assay for measuring the levels of serum antibody to Haemophilus influenzae type b. Clin Diagn Lab Immunol 1998; 5:667 - 74; PMID: 9729534
- Novartis Vaccines. Quattvaxem, product insert.
- Hla K, Thein S, Aye A, Han H, Bock H, David M, et al. Immuno- and reactogenicty profiles of a novel pentavalent DTPw-HepB/Hib vaccine: A randomised hib dose-ranging trial. 2005.
- Tregnaghi M, López P, Rocha C, Rivera L, David MP, Rüttimann R, et al. A new DTPw-HB/Hib combination vaccine for primary and booster vaccination of infants in Latin America. Rev Panam Salud Publica 2006; 19:179 - 88; http://dx.doi.org/10.1590/S1020-49892006000300006; PMID: 16640847